Abstract
Matrix metalloproteinases (MMPs) and Kruppel-like Factor 2 (KLF2) are proteins present in endothelial cells that play opposing roles in these cells in response to angiogenic and inflammatory stimuli. MMPs are endoproteases that play a large part in the degradation of various components of the extracellular matrix (ECM) and tissue remodeling. They are essential mediators of inflammation, angiogenesis, and vascular remodeling. KLF2 is a transcription factor in endothelial cells that helps maintain homeostasis and signals the endothelial cell to enter a state of quiescence. It is induced by unidirectional flow and is anti-inflammatory, anti-thrombotic, and anti-angiogenic, and promotes vasodilation. The goal of this chapter is to provide insight into this complex system by focusing on one cell type, one transcription factor, and one protease family. Herein, we review the functions of these proteins, especially in endothelial cells, and their roles in various processes, including angiogenesis, atherosclerosis, and clotting.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agren MS, Auf dem Keller U (2020) Matrix metalloproteinases: how much can they do? Int J Mol Sci 21(8)
Alcantara MB, Dass CR (2013) Regulation of MT1-MMP and MMP-2 by the serpin PEDF: a promising new target for metastatic cancer. Cell Physiol Biochem 31(4–5):487–494
Alexander JS, Elrod JW (2002) Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J Anat 200(6):561–574
Arpino V, Brock M, Gill SE (2015) The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol 44-46:247–254
Atkins GB, Jain MK (2007) Role of Kruppel-like transcription factors in endothelial biology. Circ Res 100(12):1686–1695
Bedoui Y et al (2019) Methotrexate an old drug with new tricks. Int J Mol Sci 20(20)
Bhattacharya R et al (2005) Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem 280(32):28848–28851
Cabral-Pacheco GA et al (2020) The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci 21(24)
Checchi V et al (2020) The role of matrix metalloproteinases in periodontal disease. Int J Environ Res Public Health 17(14)
Chen GH et al (2019) The molecular mechanism of EPO regulates the angiogenesis after cerebral ischemia through AMPK-KLF2 signaling pathway. Crit Rev Eukaryot Gene Expr 29(2):105–112
Chiu YL et al (2020) Ginkgo biloba induces thrombomodulin expression and tissue-type plasminogen activator secretion via the activation of Kruppel-like factor 2 within endothelial cells. Am J Chin Med 48(2):357–372
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867
Cui N, Hu M, Khalil RA (2017) Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci 147:1–73
Das H et al (2006) Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103(17):6653–6658
Das M et al (2012) Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-1beta-induced arthritis. Curr Mol Med 12(2):113–125
Das M et al (2019a) Induction of Kruppel-like factor 2 reduces K/BxN serum-induced arthritis. J Cell Mol Med 23(2):1386–1395
Das M et al (2019b) Myeloid Kruppel-like factor 2 critically regulates K/BxN serum-induced arthritis. Cell 8(8)
Deem TL, Cook-Mills JM (2004) Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 104(8):2385–2393
dela Paz NG et al (2012) Role of shear-stress-induced VEGF expression in endothelial cell survival. J Cell Sci 125(Pt 4):831–843
El-Hashim AZ et al (2012) Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-kappaB-dependent pathways. Br J Pharmacol 166(6):1964–1976
Evrard SM et al (2016) Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun 7:11853
Franco C et al (2017) Matrix metalloproteinases as regulators of periodontal inflammation. Int J Mol Sci 18(2)
Galvez BG et al (2001) Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem 276(40):37491–37500
Gimbrone MA Jr, Garcia-Cardena G (2013) Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis. Cardiovasc Pathol 22(1):9–15
Govindaraju P et al (2019) CD44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing. Matrix Biol 75–76:314–330
Heiss C, Rodriguez-Mateos A, Kelm M (2015) Central role of eNOS in the maintenance of endothelial homeostasis. Antioxid Redox Signal 22(14):1230–1242
Hiroi T et al (2009) Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Kruppel-like transcription factors. Arterioscler Thromb Vasc Biol 29(10):1587–1593
Huo N et al (2002) MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 177(1):95–100
Iivanainen E et al (2003) Endothelial cell-matrix interactions. Microsc Res Tech 60(1):13–22
Jha P, Das H (2017) KLF2 in regulation of NF-kappaB-mediated immune cell function and inflammation. Int J Mol Sci 18(11)
Koo BH et al (2010) Thrombin-dependent MMP-2 activity is regulated by heparan sulfate. J Biol Chem 285(53):41270–41279
Kumar A et al (2011) p53 impairs endothelial function by transcriptionally repressing Kruppel-like factor 2. Arterioscler Thromb Vasc Biol 31(1):133–141
Laha D, Deb M, Das H (2019) KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy. Autophagy 15(12):2063–2075
Larochelle C, Alvarez JI, Prat A (2011) How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 585(23):3770–3780
Laronha H et al (2020) Challenges in matrix metalloproteinases inhibition. Biomolecules 10(5)
Lee DY et al (2012) Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow. Proc Natl Acad Sci U S A 109(6):1967–1972
Lee GH et al (2020) Betulinic acid induces eNOS expression via the AMPK-dependent KLF2 signaling pathway. J Agric Food Chem 68(49):14523–14530
Levick SP et al (2011) Cardiac mast cells: the centrepiece in adverse myocardial remodelling. Cardiovasc Res 89(1):12–19
Lin Z et al (2006) Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation. Arterioscler Thromb Vasc Biol 26(5):1185–1189
Lin Z et al (2010) Kruppel-like factor 2 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol 30(10):1952–1959
Liu J et al (2006) Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res 4(11):803–810
Loghmani H, Conway EM (2018) Exploring traditional and nontraditional roles for thrombomodulin. Blood 132(2):148–158
Lozito TP, Tuan RS (2012) Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol 227(2):534–549
Maity J et al (2020) KLF2 regulates dental pulp-derived stem cell differentiation through the induction of mitophagy and altering mitochondrial metabolism. Redox Biol 36:101622
Meyer E et al (2005) Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis. Cancer Res 65(10):4261–4272
Moccia F et al (2019) Endothelial ca(2+) signaling, angiogenesis and vasculogenesis: just what it takes to make a blood vessel. Int J Mol Sci 20(16)
Montero I et al (2006) C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47(7):1369–1378
Moore CS, Crocker SJ (2012) An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 180(1):12–16
Nakajima H, Mochizuki N (2017) Flow pattern-dependent endothelial cell responses through transcriptional regulation. Cell Cycle 16(20):1893–1901
Nathan C (2002) Points of control in inflammation. Nature 420(6917):846–852
Newby AC (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85(1):1–31
Nicoli S et al (2010) MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464(7292):1196–1200
Niedzielski M et al (2020) New possible pharmacological targets for statins and ezetimibe. Biomed Pharmacother 129:110388
Nissinen L, Kahari VM (2014) Matrix metalloproteinases in inflammation. Biochim Biophys Acta 1840(8):2571–2580
Niu N et al (2019) Targeting mechanosensitive transcription factors in atherosclerosis. Trends Pharmacol Sci 40(4):253–266
Novodvorsky P, Chico TJ (2014) The role of the transcription factor KLF2 in vascular development and disease. Prog Mol Biol Transl Sci 124:155–188
Olejarz W, Lacheta D, Kubiak-Tomaszewska G (2020) Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability. Int J Mol Sci 21(11)
Oviedo-Orta E et al (2008) Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages. Immunology 124(1):42–50
Parks WC, Wilson CL, Lopez-Boado YS (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4(8):617–629
Pathak R et al (2014) IKKbeta regulates endothelial thrombomodulin in a Klf2-dependent manner. J Thromb Haemost 12(9):1533–1544
Posma JJ, Posthuma JJ, Spronk HM (2016) Coagulation and non-coagulation effects of thrombin. J Thromb Haemost 14(10):1908–1916
Pozzi A, Yurchenco PD, Iozzo RV (2017) The nature and biology of basement membranes. Matrix Biol 57–58:1–11
Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG (2020) Metalloproteinases and their inhibitors: potential for the development of new therapeutics. Cell 9(5)
Rempe RG, Hartz AMS, Bauer B (2016) Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab 36(9):1481–1507
Rempe RG et al (2018) Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy. J Neurosci 38(18):4301–4315
Rohani MG, Parks WC (2015) Matrix remodeling by MMPs during wound repair. Matrix Biol 44–46:113–121
Rolph DN et al (2018) Ferutinin directs dental pulp-derived stem cells towards the osteogenic lineage by epigenetically regulating canonical Wnt signaling. Biochim Biophys Acta Mol basis Dis
Rundhaug JE (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9(2):267–285
Sako K et al (2009) Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. J Biol Chem 284(9):5592–5601
SenBanerjee S et al (2004) KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199(10):1305–1315
Serra R (2020) Matrix metalloproteinases in health and disease. Biomol Ther 10(8)
Sheu BC et al (2001) A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res 61(1):237–242
Shi H et al (2013) Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Am J Physiol Heart Circ Physiol 304(6):H796–H805
Shin JW et al (2019) Molecular mechanisms of dermal aging and antiaging approaches. Int J Mol Sci 20(9)
Song J et al (2020) Upregulation of angiotensin converting enzyme 2 by shear stress reduced inflammation and proliferation in vascular endothelial cells. Biochem Biophys Res Commun 525(3):812–818
Taraboletti G et al (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160(2):673–680
Tian R et al (2019) Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2. Biochim Biophys Acta Mol basis Dis 1865(6):1701–1712
Turpaev KT (2020) Transcription factor KLF2 and its role in the regulation of inflammatory processes. Biochemistry (Mosc) 85(1):54–67
Vacek TP et al (2015) Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms. Vasc Health Risk Manag 11:173–183
Van den Steen PE et al (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96(8):2673–2681
Wang X, Khalil RA (2018) Matrix metalloproteinases, vascular remodeling, and vascular disease. Adv Pharmacol 81:241–330
Wang W et al (2010) Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS. Blood 115(14):2971–2979
Wang D et al (2017) AMPK-KLF2 signaling pathway mediates the proangiogenic effect of erythropoietin in endothelial colony-forming cells. Am J Physiol Cell Physiol 313(6):C674–C685
Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124(2):315–327
Wu C et al (2013) Abeta(1-42) disrupts the expression and function of KLF2 in Alzheimer’s disease mediated by p53. Biochem Biophys Res Commun 431(2):141–145
Yang CC et al (2018) Galangin inhibits thrombin-induced MMP-9 expression in SK-N-SH cells via protein kinase-dependent NF-kappaB phosphorylation. Int J Mol Sci 19(12)
Zhuang T et al (2019) Endothelial Foxp1 suppresses atherosclerosis via modulation of Nlrp3 Inflammasome activation. Circ Res 125(6):590–605
Acknowledgments
This work was supported in part by National Institutes of Health grants, R01AR068279 (NIAMS), STTR R42EY031196 (NEI), and STTR 1R41AG057242 (NIA). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Anderson, S., Barthels, D., Das, H. (2023). Kruppel-Like Factor 2 and Matrix Metalloproteinases in the Context of Vasculature. In: Papadimitriou, E., Mikelis, C.M. (eds) Matrix Pathobiology and Angiogenesis. Biology of Extracellular Matrix, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-031-19616-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-19616-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-19615-7
Online ISBN: 978-3-031-19616-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)